The iQ Group Global has entered into a material transfer agreement with Harvard University’s Wyss Institute to explore whether a proprietary technology developed at the Wyss Institute could be used to help provide a printable point-of-care SARS-CoV-2 antibody test for…
By Athena Kolivos, Chief Scientific Officer CRC and Farmaforce Imagine if you could be tested for SARS-CoV-2, the virus that causes the COVID-19 disease, at your local pharmacy, GP or in your own home, and receive results then and there.…
Athena Kolivos, Chief Scientific Officer CRC & Farmaforce The vaccine discovery and development experience unfolding for COVID-19 serves as a timely reminder that researching, developing and commercialising therapies to prevent, treat or cure life-threatening diseases is an extensive process; one…
